Events | December 06, 2021
Early management of Covid-19 key to reduce mortality and hospitalisation
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The fund aims at investing in companies that extends human healthspan
This further adds to Biocon’s portfolio of vertically integrated complex drug products
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
The centre has an initial capacity of 500 FTEs
Subscribe To Our Newsletter & Stay Updated
